Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06637982

Extended Platelet Rich Fibrin in Mandibular Alveolar Ridge Splitting

Thirty two healthy implants will be selected from the outpatient clinic of the oral and maxillofacial department of Mansoura university to be included in this study for replacement of lost posterior teeth with limited bone width.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mansoura University

Mansoura, Egypt, Egypt

Location contact

faisal alshammri

CONTACT

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient age 18 years old and older.
  • Patient's cooperation, motivation and good oral hygiene.
  • Atrophic posterior mandible of horizontal alveolar dimension range between 3 - 6 mm at the crest, with minimum 10 mm vertical height from the alveolar crest to the superior border of the inferior alveolar canal.
  • Absence of undercuts in buccal aspect of the ridge.
  • Favorable occlusion and no parafunctional habits.
  • Patients able to comply with the required recall visits.
  • No gender preface in selection of the patients.
  • Acceptable inter-arch space for the future prosthesis.

Exclusion criteria

  • Any pathological condition at the site of surgery.
  • Patients with systemic diseases that contra-indicate the surgical procedure such as uncontrolled diabetes mellitus, bleeding disorders, serious osseous disorders, and mental disorders.
  • Patient taking drugs that could affect bone healing process as immunosuppressive drugs and bisphosphonates.
  • Heavy smoking and alcoholism.
  • Parafunctional habits such as bruxism and clenching.
  • Signs of acute infection or pus discharge.
  • Untreated periodontal disease or bad oral hygiene.

Treatment and study plan

ridge splitting with the use of allograft and pericardium membrane

Procedure

ridge splitting with the use of allograft and pericardium membrane

ridge splitting with the use of extended platelet rich fibrin

Procedure

ridge splitting with the use of extended platelet rich fibrin

Primary outcomes

  1. implant stability

    Time frame: 9 months

    the stability of the implants will be evaluated by RFA with the Osstell Mentor device

  2. alveolar ridge width

    Time frame: 9 months

    alveolar ridge width will be measured preoperative, immediate postoperative and after 9 months

Study contacts

Contact information is provided by the study sponsor or research team.

faisal alshammri

CONTACT

[email protected]

1555250898 ext. 0020

Sponsors and collaborators

Lead sponsor

Mansoura University

Other

Registry information

Official study title

Extended Platelet Rich Fibrin in Mandibular Alveolar Ridge Splitting With Simultaneous Implant Placement

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Oct 15, 2024
Registry last updated
Oct 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.